Activities of acyclic nucleoside phosphonates against orf virus in human and ovine cell monolayers and organotypic ovine raft cultures

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 12, 2005, Pages 4843-4852

  Dal Pozzo, F ^a,d   Andrei, G ^a   Holy A ^b   Van Den Oord, J ^c   Scagliarini, A ^d   De Clercq, E ^a   Snoeck, R ^a,d  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d Alma Mater Studiorum ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

9 [3 HYDROXY 2 (PHOSPHONOMETHOXY)PROPYL] 2,4 DIAMINOPYRIMIDINE; 9 [3 HYDROXY 2 (PHOSPHONOMETHOXY)PROPYL] 2,6 DIAMINOPURINE; ACYCLIC NUCLEOSIDE; CIDOFOVIR; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DERMATITIS; EPITHELIUM; FETUS LUNG; GOAT; IC 50; KERATINOCYTE; LAMB; MOUSE; NONHUMAN; POXVIRUS; POXVIRUS INFECTION; PRIORITY JOURNAL; SHEEP; VIRUS REPLICATION; VIRUS TITRATION;

ADENINE; ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CYTOSINE; HUMANS; KERATINOCYTES; NUCLEOSIDES; ORF VIRUS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHONIC ACIDS; SHEEP;

EID: 28844451043     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.12.4843-4852.2005     Document Type: Article

References (34)

1. Balzarini, J., C. Pannecouque, L. Naesens, G. Andrei, R. Snoeck, E. De Clercq, D. Hocková, and A. Holý. 2004. 6-[2-(Phosphonomethoxy) alkoxy]-2,4-diaminopyrimidines: a new class of acyclic pyrimidine nucleoside phosphonates with antiviral activity. Nucleosides Nucleotides Nucleic Acids 23:1321-1327.
2. Crumbie, A. 1998. The orf virus: a disease of the farming community. Community Nurse 4:44-45.
3. De Clercq, E. 2002. Cidofovir in the treatment of poxvirus infections. Antivir. Res. 55:1-13.
4. De Clercq, E. 2003. Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections. Clin. Microbiol. Rev. 16:569-596.
5. De Clercq, E., T. Sakuma, M. Baba, R. Pauwels, J. Balzarini, I. Rosenberg, and A. Holý. 1987. Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines. Antivir. Res. 8:261-272.
6. Degraeve, C., A. De Coninck, J. Senneseael, and D. Roseeuw. 1999. Recurrent contagious ecthyma (Orf) in an immunocompromised host successfully treated with cryotherapy. Dermatology 198:162-163.
7. Geerinck, K., G. Lukito, R. Snoeck, R. De Vos, E. De Clercq, Y. Vanrenterghem, H. Degreef, and B. Maes. 2001. A case of human orf in an immunocompromised patient successfully treated with cidofovir cream. J. Med. Virol. 64:543-549.
8. Gilray, J. A., P. F. Nettleton, I. Pow, C. J. Lewis, S. A. Stephens, J. D. Madeley, and H. W. Reid. 1998. Restriction endonuclease profiles of orf virus isolates from British Isles. Vet. Rec. 143:237-240.
9. Haig, D. M., and A. A. Mercer. 1998. Ovine diseases. Orf. Vet. Res. 29:311-326.
10. Haig, D. M., C. McInnes, D. Deane, H. Reid, and A. Mercer. 1997. The immune and inflammatory response to orf virus. Comp. Immunol. Microbiol. Infect. Dis. 20:197-204.
11. Hansen, E., A. Nyfors, A. Naess, and H. Sjursen. 1984. Erythema multiforme major (Stevens-Johnson syndrome) caused by orf virus infection. Tidsskr. Nor. Laegeforen. 104:978-979.
12. Holý, A. 2003. Phosphonomethoxyalkyl analogs of nucleotides. Curr. Pharm. Des. 9:2567-2592.
13. Holý, A., I. Votruba, M. Masojídkovà, G. Andrei, R. Snoeck, L. Naesens, E. De Clercq, and J. Balzarini. 2002. 6-[2- (Phosphonomethoxy)alkoxy]-pyrimidines with antiviral activity. J. Med. Chem. 45:1918-1929.
14. Holý, A., and M. Masojídková. Synthesis of 9-[2-(Phosphonomethoxy)-ethyl]-2,6-diaminopurine (PMEDAP) derivatives substituted at 6-amino function by groups with acid characteristic. Collect. Czech. Chem. Commun., in press.
15. Hooser, S. B., G. Scherba, D. E. Morin, and H. E. Whiteley. 1989. Atypical contagious ecthyma in a sheep after extensive cutaneous thermal injury. J. Am. Vet. Med. Assoc. 195:1255-1256.
16. Hunskaar, S. 1986. Giant orf in a patient with chronic lymphocytic leukaemia. Br. J. Dermatol. 114:631-634.
17. Inoshima, Y., A. Morooka, and H. Sentsui. 2000. Detection and diagnosis of parapoxvirus by polymerase chain reaction. J. Virol. Methods 8:201-208.
18. Leavell, U. W., Jr., M. J. McNamara, R. Muelling, W. M. Talbert, R. C. Rucker, and A. J. Dalton. 1968. Orf. Report of 19 human cases with clinical and pathological observations. JAMA 203:657-664.
19. Mazur, C., and R. D. Machado. 1989. Detection of contagious pustular dermatitis virus of goats in a severe outbreak. Vet. Rec. 125:419-420.
20. McKeever, D. J., D. M. Jenkinson, G. Hutchison, and H. W. Reid. 1988. Studies of the pathogenesis of orf virus infection in sheep. J. Comp. Pathol. 99:317-328.
21. Meyers, C., and L. A. Laimins. 1994. In vitro systems for the study and propagation of human papillomaviruses. Curr. Top. Microbiol. Immunol. 186:199-215.
22. Meyers, C., M. Mane, N. Kokorina, S. Alam, and P. L. Hermonat. 2000. Ubiquitous human adeno-associated virus type 2 autonomously replicates in differentiating keratinocytes of a normal skin model. Virology 272:338-346.
23. Mourtada, I., M. Le Tourneur, J. Chevrant-Breton, and F. Le Galle. 2000. Human orf and erythema multiforme. Ann. Dermatol. Venereol. 127:397-399.
24. Murphy, J. K., and I. G. Ralfs. 1996. Bullous pemphigoid complicating human orf. Br. J. Dermatol. 134:929-930.
25. Nettleton, P. F., J. A. Gilray, H. W. Reid, and A. A. Mercer. 2000. Parapox-viruses are strongly inhibited in vitro by cidofovir. Antivir. Res. 48:205-208.
26. Neyts, J., R. Snoeck, J. Balzarini, and E. De Clercq. 1991. Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC) in vitro. Antivir. Res. 16:41-52.
27. Robinson, A. J., G. Ellis, and T. Balassu. 1982. The genome of orf virus: restriction endonuclease analysis of viral DNA isolated from lesions of orf in sheep. Arch. Virol. 71:43-55.
28. Smith, G. W., G. Scherba, P. D. Constable, V. Hsiao, M. J. Behr, and D. E. Morin. 2002. Atypical parapoxvirus infection in sheep. J. Vet. Intern. Med. 16:287-292.
29. Snoeck, R., A. Holý, C. Dewolf-Peeters, J. Van Den Oord, E. De Clercq, and G. Andrei. 2002. Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures. Antimicrob. Agents Chemother. 46:3356-3361.
30. Snoeck, R., and E. De Clercq. 2002. Role of cidofovir in the treatment of DNA virus infections, other than CMV infections, in immunocompromised patients. Curr. Opin. Investig. Drugs 3:1561-1566.
31. Tan, S. T., G. B. Blake, and S. Chambers. 1991. Recurrent orf in an immunocompromised host. Br. J. Plast. Surg. 44:465-467.
32. Visalli, R. J., R. J. Courtney, and C. Meyers. 1997. Infection and replication of herpes simplex virus type 1 in an organotypic epithelial culture system. Virology 230:236-243.
33. Yirrell, D. L., J. P. Vestey, and M. Norval. 1994. Immune responses of patients to orf virus infection. Br. J. Dermatol. 130:438-443.
34. Zabawski, E. J., Jr., and C. J. Cockerell. 1999. Topical cidofovir for molluscum contagiosum in children. Pediatr. Dermatol. 16:414-415.